Cite

HARVARD Citation

    Epperly, R. et al. (2021). Targeting plasma cells with daratumumab aids in the treatment of post‐transplant autoimmune‐like hepatitis. Pediatric blood & cancer. 68 (11), p. n/a. [Online]. 
  
Back to record